Antimalarial class drugs

6 results
  • atovaquone

    (Atovaquone)
    Bionpharma Inc.
    Atovaquone oral suspension is indicated for the prevention and treatment of mild-to-moderate Pneumocystis jirovecii pneumonia (PCP) in adults and adolescents (13 years and older) who cannot tolerate trimethoprim-sulfamethoxazole (TMP-SMX). Its efficacy in severe cases or in patients failing TMP-SMX therapy is not established.
  • chloroquine phosphate

    (chloroquine phosphate)
    Chartwell RX, LLC
    Chloroquine phosphate tablets are indicated for treating uncomplicated malaria caused by certain Plasmodium species, and for malaria prophylaxis in areas without resistance. They are also used to treat extraintestinal amebiasis. Limitations include ineffectiveness against specific malaria forms and contraindications in complicated cases or resistant areas.
  • hydroxychloroquine

    (Hydroxychloroquine)
    Chartwell RX, LLC
    Hydroxychloroquine sulfate is indicated for the treatment of uncomplicated malaria, rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in adults and pediatric patients. It also offers malaria prophylaxis in areas without chloroquine resistance. Not recommended for complicated or resistant malaria cases.
  • hydroxychloroquine sulfate

    (Hydroxychloroquine Sulfate)
    Amneal Pharmaceuticals NY LLC
    Hydroxychloroquine sulfate tablets are indicated for treating uncomplicated malaria, rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus. Prophylaxis of malaria is also indicated in areas without chloroquine resistance. It is not recommended for complicated malaria or resistant strains.
  • hydroxychloroquine sulfate

    (HYDROXYCHLOROQUINE SULFATE)
    Dr. Reddy's Laboratories Inc.
    Hydroxychloroquine sulfate is indicated for treating uncomplicated malaria, rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in adults and pediatric patients. It is also used for malaria prophylaxis in areas without chloroquine resistance. Limitations apply to certain malaria strains and treatment scenarios.